Frankfurt
14.04.26 | 08:16
0,082 Euro
-25,36 % -0,028
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,106 | 0,112 | 14.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard | 234 | Business Wire | Integration of PediGuard systems into Omnia Medical's portfolio across a broad range of spine indications, including minimally invasive and outpatient treatments Transaction supports SpineGuard's... ► Artikel lesen | |
| 08.04. | SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing | 292 | Business Wire | Operating income improved by 46% Cash runaway extended to 2Q27
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 25.03. | SpineGuard Announces the Full Settlement of the Norgine and Harbert European Growth Bond Issues | 383 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD, PEA-PME eligible), an innovative company deploying its digital surgical guidance (DSG) technology-which measures tissue electrical conductivity... ► Artikel lesen | |
| 19.01. | SpineGuard Reports Its Full-year 2025 Revenue | 354 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its digital surgical guidance (DSG) technology, which measures the electrical conductivity of tissues in real... ► Artikel lesen | |
| 05.01. | SpineGuard Announces its 2026 Financial Calendar | 397 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 17.12.25 | PhD Thesis Presentation of Positive Results Obtained by SpineGuard's New Ultrasound Technology | 370 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
| 16.12.25 | SpineGuard: Completion of Capital Increase With Priority Period Maintained for a Gross Amount of €1.2 Million | 323 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its digital surgical guidance (DSG) technology based on local measurement of tissue electrical... ► Artikel lesen | |
| 09.12.25 | SpineGuard announces the launch of a capital increase with cancellation of preferential subscription rights and implementation of a priority period for shareholders for an initial gross amount of €1.6 million secured by commitments amounting to... | 521 | Business Wire | Subscription price: €0.1120 per share, representing a discount of 25.93% on the closing price of the share on December 8th, 2025 Priority period open from December 9th, 2025, to December... ► Artikel lesen | |
| SPINEGUARD Aktie jetzt für 0€ handeln | |||||
| 04.12.25 | SpineGuard Obtains the Clearance of Three New PediGuard Models in China | 373 | Business Wire | Extension to add the Curved and XS PediGuard models
Designation change
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 24.11.25 | SpineGuard Obtains a U.S. Patent on Its Universal Adapter for Orthopaedic Power Drills and Robots | 322 | Business Wire | Bone breach detection, automatic stop and additional functionalities
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 09.10.25 | SpineGuard Reports Its Q3 2025 Revenue | 434 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 22.09.25 | SpineGuard Obtains European Patent on Automatic Bone Breach Detection by DSG, Applicable to Orthopedic Power Drills and Robots | 385 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
| 10.09.25 | SpineGuard Reports 2025 Half-Year Results and Announces the Implementation of a Bond Financing | 585 | Business Wire | 54% improvement in operating result Implementation of a bond financing for up to €1,000,000
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its... ► Artikel lesen | |
| 16.07.25 | SpineGuard Obtains US Patent on DSG-Enabled Active Safety Stop for Hand-Held Bone Drilling Power Tools in Free-Hand, Navigated or Robotically-Assisted Surgery | 541 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 09.07.25 | SpineGuard Announces Its H1 2025 Revenue | 499 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 29.04.25 | Presentation at CFA Congress of Positive Results Obtained for SpineGuard's New Ultrasound Technology | 578 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
| 15.04.25 | SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales | 666 | Business Wire | Significant reduction in losses of €1.1 million, with consolidated net income improving by 26% in 2024
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,850 | +0,81 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,290 | +1,32 % | Multinational Execs in China Must Act as Entrepreneurs, Siemens Healthineers Country President Says | ||
| THERMO FISHER | 448,20 | +0,20 % | Thermo Fisher Scientific, HealthVerity Partner to Expand Real-World Data Capabilities | ||
| TELADOC HEALTH | 4,427 | -0,47 % | Pineal Capital Management Issues Open Letter to the Board of Teladoc Health, Inc. | DUBLIN, March 31, 2026 (GLOBE NEWSWIRE) -- The following is an open letter issued by Pineal Capital Management:
Board of DirectorsTeladoc Health, Inc.2 Manhattanville Road, Suite 203Purchase, NY... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 68,28 | -0,32 % | Eurofins Scientific To Divest Electrical & Electronic Testing Business | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Eurofins Scientific SE (EUFI.PA, ERF.PA) announced the signing of an agreement to divest its Electrical & Electronic Testing business, or MET Labs, to UL... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| DAVITA | 126,80 | 0,00 % | DaVita: The Doctor Will See You Now: The Value of Human Connection in AI-Supported Medicine | As artificial intelligence (AI) continues to take hold across all industries, Adam Weinstein, MD, chief medical information officer for DaVita, highlights how new technological capabilities also help... ► Artikel lesen | |
| SPINEWAY | 0,150 | +1,63 % | SPINEWAY: Minutes of the General Meeting of April 2, 2026 | Ecully, April 7, 2026 - 8:00 a.m. SPINEWAY Minutes of the General Meeting of April 2, 2026 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice... ► Artikel lesen | |
| DENTSPLY SIRONA | 10,350 | 0,00 % | Dentsply Sirona: First-ever Dental Dedicated MRI System Validated In Trial, Cleared By FDA | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Dentsply Sirona (XRAY) and Siemens Healthineers (SHL.DE) announced that the dental-dedicated ddMRI system - MAGNETOM Free.Max Dental Edition - has received... ► Artikel lesen | |
| SMITH & NEPHEW | 14,200 | -3,40 % | Smith & Nephew Plc: Smith+Nephew's REGENETEN? Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* | Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff repair
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today... ► Artikel lesen | |
| SONIC HEALTHCARE | 12,180 | -0,07 % | SONIC HEALTHCARE LIMITED: Change in substantial holding | ||
| DIASORIN | 62,92 | -0,25 % | DiaSorin FY Net Result Down | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI, DSRLF, DIAS.MI) reported that its net result for fiscal year 2025 declined to 150 million euros from 187 million euros last year.But net revenues for... ► Artikel lesen | |
| FULGENT GENETICS | 13,500 | +0,75 % | Fulgent Genetics completes $56.9M pathology lab acquisitions | ||
| IMPLANTICA | 4,445 | -0,22 % | Implantica publishes Year-end Report, January - December 2025 (Q4) | VADUZ, Liechtenstein, March 26, 2026 /PRNewswire/ --
RefluxStop US Launch Coming Closer, pending FDA approvalSignificant events in the fourth quarter FDA completed six pre-approval... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 3,560 | 0,00 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results | Lead program VMT-a-NET in neuroendocrine tumors continues to demonstrate a favorable tolerability profile with durable disease control and deepening of tumor response with longer follow-up, as reported... ► Artikel lesen |
SPINEGUARD SA gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,028 (-25,36 %) liegt der Kurs bei 0,082 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SPINEGUARD SA finden Sie auf Wallstreet Online.